Skip to content

Vitamin D Supplementation and Muscle Characteristics in Trained Subjects

Effects of 12 Weeks of Vitamin D Supplementation on Muscle Characteristics in Trained Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02599675
Enrollment
71
Registered
2015-11-06
Start date
2015-11-30
Completion date
2017-02-28
Last updated
2017-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects, Trained

Keywords

Muscle, Vitamin D, Strength, Endurance, Muscle fiber

Brief summary

This study evaluates the effect of vitamin D supplementation on outcomes muscle performance and characteristics in 70 trained healthy individuals (18-40 years of age). Subjects will be allocated to ingest either vitamin D (35) or placebo (35) in a double-blinded fashion

Detailed description

Vitamin D insufficiency compromises muscle functionality, leading to changes in muscle mass and strength, manifested at the cellular level. While this is increasingly recognized as a problem for individuals with vitamin D deficiency (typically 25(OH)D \< 25 nmol/l), there is no general consensus for the remainder of the vitamin D-spectra. This lack of knowledge is probably linked to the variation in protocols of studies that have investigated the physiological role of vitamin D. These variations vary from aspects such as interventional vs observational studies to aspects related to subject characteristics such as age, health and training status. In this project, we will evaluate the effects of 12 weeks of vitamin D supplementation (2000 IU/day) on muscle performance and characteristics in 70 trained healthy individuals (18-40 years of age). Subjects will be allocated to either a vitamin D (35) or a placebo group (35) in a double-blinded manner. They will be instructed to continue their ordinary modes and frequency of training. We anticipate baseline vitamin D levels in blood (and hence changes in vitamin D obtained through supplementation), measured as 25(OH)D, to be a major determinant of the efficacy of the intervention. This means that we expect individuals with low baseline levels of 25(OH)D to display more pronounced changes in functional and biological outcome measures than those with high baseline values. Such a scenario could be related to an inability of our protocol to increase blood levels of 25(OH)D in individuals with higher physiological levels of vitamin D (which essentially means that ingestion of vitamin D3 is leveled out or exceeded by elimination of vitamin D derivatives). Alternatively, it may be related to inabilities of tissues to respond to the resulting elevation in vitamin D levels. To study the individual variation in vitamin D responses, data on both functional and biological variables will be divided into quartiles based on baseline 25(OH)D-levels, whereupon comparisons will be made between the low-end and high-end quartile. Individual variation will also be assessed using a mixed model approach.

Interventions

DIETARY_SUPPLEMENTVitamin D3

Vitamin D3 dissolved in olive oil, encapsuled

DIETARY_SUPPLEMENTPlacebo

Olive oil, encapsuled

Sponsors

Sykehuset Innlandet HF
CollaboratorOTHER
Inland Norway University of Applied Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

\- Individuals that have performed strength and / or endurance exercise training at least 3 X week for at least 6 months prior to the study

Design outcomes

Primary

MeasureTime frameDescription
Muscle fiber compositionwk0, wk12Changes of the muscle fiber composition of musculus vastus lateralis in a 2X to 2A direction, measured using mRNA profiling
Lower body maximal dynamic strengthwk 0, wk12Changes in the ability of lower body muscles to exert maximal force during a dynamic movement

Secondary

MeasureTime frameDescription
Vitamin D in bloodwk0, wk12Changes in levels of 25(OH)D in blood
Steroid hormones in bloodwk0, wk12Changes in levels of steroid hormones in blood
Gene expression in musclewk0, wk12Changes in RNA abundances in musculus vastus lateralis, measured at the level of single genes
Muscular endurancewk0, wk12Changes in the ability of muscles to perform repeated dynamic contractions at submaximal loads (50% of 1 repetition maximum)
Upper body maximal dynamic strengthwk0, wk12Changes in the ability of upper body muscles to exert maximal force during dynamic movements

Other

MeasureTime frameDescription
Vitamin D-intake diaryFrom 1 month prior to study to post test (w12)Diary withthat includes information on approximate intake of vitamin D from sources other than the study-specific supplement, including ingestion of fish, seafood and vitamin D-supplement
Training diaryFrom 1 month prior to study to post test (w12)Diary that includes information on type of training, duration and intensity performed
Sun exposure diaryFrom 1 month prior to study to post test (w12)Diary that includes information on exposure to solarium or sun in countries south of Norway

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026